Lv3
238 积分 2025-01-20 加入
Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis
23天前
已完结
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial
1个月前
已完结
Head and neck squamous cell carcinoma
1个月前
已完结
Head and Neck Cancer
1个月前
已完结
Head and Neck Cancer
1个月前
已完结
The molecular landscape of head and neck cancer
1个月前
已完结
Head and Neck Cancer
1个月前
已完结
Radiotherapy reimagined: Integrating nanomedicines into radiotherapy clinical trials
1个月前
已完结
Nanoparticle radiosensitizers in cancer radiotherapy: bridging preclinical promise and clinical reality
1个月前
已完结
Nanoscale Radiotherapy with Hafnium Oxide Nanoparticles
1个月前
已完结
皖公网安备34019202002308
